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Purpose: To report the preoperative best-corrected visual acuity (BCVA) and foveal thickness 
(FT) values that lead to a postoperative decimal BCVA of 1.0 after surgical removal of an 
idiopathic epiretinal membrane (ERM).
Methods: This is a retrospective case series of 73 eyes that underwent surgery for removal of 
an idiopathic ERM. All eyes had been treated by a single surgeon using a 25-gauge transcon-
junctival sutureless vitrectomy and indocyanine green-assisted internal limiting membrane peel. 
The BCVA and FT were measured at baseline and 6 months postoperatively.
Results: A postoperative decimal BCVA  1.0 was obtained in eyes with a preoperative   decimal 
BCVA  0.3 but not in those with a preoperative decimal BCVA # 0.2. The incidence of obtain-
ing a postoperative decimal BCVA  1.0 was significantly (P = 0.002) higher in eyes with a 
preoperative decimal BCVA  0.5 (50%) than in eyes with a preoperative decimal BCVA < 0.5 
(11%). Additionally, a postoperative decimal BCVA of 1.0 was obtained in 51% of the eyes 
that had a preoperative FT , 400 µm, compared with only 21% of eyes with a preoperative 
FT  400 µm (P = 0.01). The incidence of obtaining a postoperative decimal BCVA  1.0 was 
significantly higher in eyes with preoperative decimal BCVA  0.5 and FT < 400 µm (60%) 
than in eyes with preoperative decimal BCVA  0.5 and FT  400 µm (20%; P = 0.03 ) or 
preoperative BCVA < 0.5 and FT  400 µm (7%; P < 0.001).
Conclusions: These findings indicate that eyes with both preoperative BCVA  0.5 and 
FT , 400 µm have a significantly better chance of obtaining a postoperative decimal 
BCVA  1.0 following idiopathic ERM removal.
Keywords: 25-gauge vitrectomy, optical coherence tomography, epimacular membrane, 
epiretinal membrane, visual acuity, foveal thickness
Introduction
The surgical indications for the removal of an epiretinal membrane (ERM) have 
not been standardized. The removal of an ERM is helpful for many patients, but 
the surgical complications, such as endophthalmitis and retinal detachment, can 
negate the   effectiveness of the removal.1–3 Because eyes with an idiopathic ERM have 
moderately good preoperative vision, the eyes to undergo surgery to remove an ERM 
should be carefully selected. The selection depends on the patient’s symptoms and 
visual requirements, and the vitreous surgeon’s technique. A postoperative decimal 
best-corrected visual acuity (BCVA)  1.0 (BCVA Snellen chart  20/20) is a posi-
tive result of removing an idiopathic ERM.4–7
A 25-gauge transconjunctival sutureless vitrectomy (25G-TSV) and membranectomy 
for the treatment of idiopathic ERM was first reported in 2002 by Fuji et al.8,9 This Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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procedure has evolved and become more common over 
the years. The main   advantage of this technique is that the 
  intraoperative procedure is   sutureless, meaning that the 
wounds are self-sealing. This reduces   postoperative ocular 
pain and discomfort and procedure time, as well as the com-
plications (eg, inflammation, astigmatism). In   addition, using 
a 25G-TSV for the treatment of an   idiopathic ERM leads to 
earlier postoperative visual improvement, compared with 
conventional 20-gauge vitrectomy.10,11 Because 25G-TSV 
retains the vitreous, the possibility of endophthalmitis has 
been discussed for many years, but a recent multicenter report 
of over 40,000 cases indicated no difference.12
Though there are many reports of postoperative   favorable 
visual outcomes and visual improvements that may not 
be exactly defined as decimal BCVA  1.0, we could not 
find any reports on preoperative findings that ensure a 
postoperative decimal BCVA  1.0 in patients with ERMs. 
The purpose of this study was to determine the preoperative 
BCVA and foveal thickness (FT) in eyes with an idiopathic 
ERM that would help predict a postoperative BCVA  1.0 
following 25G-TSV/membranectomy.
Patients and methods
Participants
This was a retrospective case series of 73 eyes of 73 patients 
with idiopathic ERMs who underwent 25G-TSV (Alcon 
Laboratories; Fort Worth, TX, USA)/membranectomy. The 
inclusion criterion was a clinically detectable idiopathic ERM 
diagnosed by fundus examination or optical coherence tomog-
raphy (OCT), causing a decrease of visual acuity or metamor-
phopsia as reported by the patient; a questionnaire; or Amsler 
grid findings. The exclusion criteria included prior vitreous 
surgery, prior intravitreal injection of triamcinolone acetonide 
or antivascular endothelial growth factor, ocular inflammation, 
prior scleral buckling, prior trauma, and eyes with complex 
vitreoretinal disease such as proliferative vitreoretinopathy 
or proliferative diabetic retinopathy. None of the patients was 
excluded because of a decimal BCVA , 0.05. The preoperative 
demographics of the patients are shown in Table 1.
All of the surgeries were performed at the Surgical Retina 
Clinic of the Tohoku University Hospital, Sendai, Japan, 
from July 2006 to November 2008. After the purpose and 
procedures of the operation were explained, an informed 
consent was obtained from all patients. The procedures used 
conformed to the tenets of the Declaration of Helsinki and 
were approved by the Review Board of the School of Medi-
cine, Tohoku University.
surgical procedures
All surgeries were performed under retrobulbar anesthesia 
by a single surgeon (HK). A conjunctival peritomy was not 
made in all cases, and all surgeries were performed with 
the 25G Accurus Vitrectomy System (Alcon Laboratories). 
Patients with concomitant lenticular changes had a combined 
sutureless 25G-TSV and phacoemulsification.
After resecting the vitreal core, about 4 mg of triamci-
nolone acetonide (TA; Kenacort-A, Bristol-Myers Squibb, 
Tokyo, Japan) was injected into the vitreous cavity to 
determine whether a posterior vitreous detachment (PVD) 
was   present. If a PVD was not present, we created a PVD 
with a 25-gauge cutter. After creating a PVD and removing 
residual gel, the epiretinal   membrane was removed without 
using any dye. In   addition, the internal limiting membrane 
(ILM) was removed using indocyanine green (ICG; Santen 
Co., Osaka, Japan) to improve visibility. The ICG crystals 
were reconstituted in 1.00 mL distilled water to produce a 
  concentration of 25 mg/mL. Further dilutions were made with 
Table 1 summary of clinical data
Characteristics Value P value
eyes (no.) 73
Patients (no./%) 73
  Male 24 (33)
  Female 49 (67)
Age (yrs)
  Mean ± sD 67.2 ± 10.4
  Median 68
  range 28–87
Lens status (baseline; no./%)
  Phakic 61 (84)
  Pseudophakic 12 (16)
surgical procedure (no./%)
  25g-TsV 34 (47)
  Triple surgery 39 (53)
Decimal BCVA (mean)
  Baseline 0.59
  Postoperative 6M 0.74
BCVA (logMAr; mean ± sD)
  Baseline 0.23 ± 0.25
  Postoperative 6M 0.13 ± 0.27 ,0.001*
  improvement 0.10 ± 0.21
Foveal thickness (µm; mean (sD)
  Baseline 371 ± 106
  Postoperative 6M 300 ± 67 ,0.001*
  reduction 71 ± 43
Notes:  *Wilcoxon  signed–rank  test,  Postoperative  6M  versus  baseline.  Triple 
surgery, phaceomulsification and aspiration, intraocularlens implant, and 25-gauge 
transconjunctival sutureless vitrectomy.
Abbreviations:  sD,  standard  deviation;  25g-TsV,  25-gauge  transconjunctival 
sutureless vitrectomy; BCVA, best-corrected visual acuity; logMAr, logarithm of   
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19 mL   balanced salt solution. Thus, the final concentration of 
ICG was 1.25 mg/mL, and approximately 0.2 mL of it was 
injected around the ERM.
Postoperatively, both antibiotics and corticosteroids 
were injected subconjunctivally in all cases. We used topical 
nonsteroidal anti-inflammatory drugs for all cases for at least 
3 months after the membrane peel.
Measurements of clinical findings
All of the patients had a complete ophthalmological examina-
tion, including BCVA and FT measurements preoperatively 
and at 6 months postoperatively. The BCVA was determined 
with a standard Japanese Landolt visual acuity chart. FT was 
measured by OCT (Zeiss-Humphrey model OCT-3000, 
Dublin, CA, USA) before and after the 25G-TSV . The retinal 
thickness of the central fovea was defined as the distance 
between the ILM and the retinal pigment epithelium and was 
automatically calculated by the software of the OCT.
statistical analyses
The data are presented as mean ± standard deviation. 
The   significance of the differences between the pre- and 
post-25G-TSV data was determined by Wilcoxon signed-rank 
tests. To obtain a postoperative decimal BCVA  1.0, the 
  distribution of preoperative decimal BCVA and   preoperative 
FT was assessed by Fisher’s exact probability test. The   decimal 
BCVA was converted to a logarithm of the minimal angle 
  resolution (logMAR) units for   statistical analyses. Spearman’s 
rank correlation coefficient was   calculated to determine the 
correlation between postoperative BCVA (logMAR) and 
preoperative BCVA (logMAR), and between   postoperative 
BCVA (logMAR) and preoperative FT. A P value , 0.05 
was considered to be statistically significant.
Results
A summary of the clinical data is shown in Table 1. The patients 
included 24 men and 49 women whose mean ±   standard 
deviation age was 67.2 ± 10.4 years. The mean postopera-
tive follow-up period was 9.8 ± 3.5 months with a range 
of 6–21 months. The mean preoperative BCVA was 0.59 
(decimal) or 0.23 logMAR units.   Phacoemulsification and 
aspiration, intraocular lens implantation, and 25G-TSV 
were performed on 39 eyes (53%), and 25G-TSV only was 
performed on 34 eyes (47%). In the 22 phakic eyes that had 
ERM surgery without cataract surgery, there was only one 
patient whose lens sclerosis progressed postoperatively, and 
cataract surgery was performed after 5 months from the initial 
ERM surgery. None of the patients required suturing of the 
sclerotomy site at the end of the initial surgery.
The mean postoperative BCVA at 6 months was 
0.13 ± 0.27 logMAR units, which was significantly   better 
than the preoperative BCVA of 0.23 ± 0.25 logMAR units 
(P , 0.001, Wilcoxon signed-rank test). The mean postop-
erative FT was 300 ± 67 µm, which was significantly   thinner 
than the preoperative FT of 371 ± 106 µm (P , 0.001, 
  Wilcoxon signed-rank test).
A summary of the correlations between the BCVA 
and FT is shown in Table 2. The preoperative BCVA (in 
logMAR units) was significantly correlated to the preopera-
tive FT (r = 0.43, P , 0.001, Spearman’s rank correlation 
coefficient). The postoperative BCVA was significantly 
correlated with the postoperative FT (r = 0.26, P = 0.03, 
Spearman’s rank correlation coefficient). The preoperative 
BCVA was significantly correlated with the postoperative 
BCVA (r = 0.44, P , 0.001, Spearman’s rank correla-
tion coefficient, Figure 1). The preoperative FT was also 
significantly correlated with the postoperative BCVA 
(r = 0.24, P = 0.04, Spearman’s rank correlation coefficient, 
Figure 2). The mean of the visual improvement (preoperative 
BCVA –   postoperative BCVA in logMAR units) was 0.10 
logMAR units, and this improvement was correlated with 
the preoperative BCVA (r = 0.55, P , 0.001,   Spearman’s 
rank correlation coefficient). Thus, the postoperative 
visual improvement was greater in eyes with initially 
poorer preoperative vision. However, the postoperative 
visual improvement was not significantly correlated with 
the preoperative FT (r = 0.21, P = 0.07, Spearman’s rank 
correlation coefficient). The reduction of FT   (preoperative 
FT – postoperative FT) was strongly correlated with the 
preoperative FT (r = 0.80, P , 0.001,   Spearman’s rank 
correlation coefficient). The reduction of FT was greater in 
Table 2 Correlation between visual acuity and foveal thickness
r value P value
reduction of FT Preoperative FT 0.80 ,0.001*
Visual improvement Preoperative BCVA 0.55 ,0.001*
Postoperative BCVA Preoperative BCVA 0.44 ,0.001*
Preoperative BCVA Preoperative FT 0.43 ,0.001*
reduction of FT Preoperative BCVA 0.31 0.008*
Postoperative BCVA Postoperative FT 0.26 0.03*
Visual improvement reduction of FT 0.24 0.04*
Postoperative BCVA Preoperative FT 0.24 0.04*
Notes: *Spearman’s correlation coefficient by rank. Reduction of FT, preoperative 
FT – postoperative FT; Visual improvement, preoperative BCVA – postoperative 
BCVA in logMAr units.
Abbreviations: FT, foveal thickness (µm); BCVA, best-corrected visual acuity in 
logarithm of the minimum angle of resolution (logMAr). Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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eyes with thicker   preoperative FT. The reduction of FT was 
also significantly correlated with the preoperative BCVA 
and postoperative visual improvement (r = 0.31, P = 0.008, 
and r = 0.24, P = 0.04, respectively, Spearman’s rank cor-
relation coefficient). 
The associations between a preoperative decimal 
BCVA and a postoperative decimal BCVA  1.0 are 
shown in Table 3. A postoperative decimal BCVA  1.0 
was obtained in 29 eyes with a   preoperative decimal 
BCVA  0.3, but none of the eyes with a preoperative 
decimal BCVA # 0.2 showed a postoperative decimal 
BCVA  1.0. The likelihood of obtaining a postoperative 
decimal BCVA  1.0 was 57% (12/21 eyes) in eyes with a 
preoperative decimal BCVA  0.9, 47% (7/15 eyes) in eyes 
with preoperative decimal BCVA of 0.7–0.8, 44% (8/18 
eyes) in eyes with preoperative decimal BCVA of 0.5–0.6, 
and 13% (2/15 eyes) in eyes with preoperative decimal 
BCVA of 0.3–0.4. The likelihood of obtaining a postopera-
tive decimal BCVA  1.0 was significantly higher in eyes 
with a   preoperative decimal BCVA  0.9 than preoperative 
decimal BCVA of 0.3–0.4 (P = 0.008 Fisher’s exact 
probability test). The likelihood of obtaining a postoperative 
decimal BCVA  1.0 was significantly higher in eyes with a 
preoperative decimal BCVA  0.5 than preoperative decimal 
BCVA < 0.5 (P = 0.002, Fisher’s exact probability test). In 
addition, there was no significant   difference in the likelihood 
of obtaining a postoperative decimal BCVA  1.0 between 
preoperative decimal BCVA  0.9 and decimal BCVA of 
0.7–0.8 and decimal BCVA of 0.5–0.6 (Table 3).
The associations between the preoperative FT and 
postoperative decimal BCVA  1.0 are shown in Table 4. 
The likelihood of obtaining a postoperative decimal 
BCVA  1.0 was 21% (6/28 eyes) in eyes with a preopera-
tive FT of 400 µm, 56% (14/25 eyes) with a preoperative 
FT of 300 to 399 µm, 47% (9/19 eyes) with a preopera-
tive FT of 200–299 µm, and 0% (0/1 eyes) in eyes with a 
preoperative FT of 100–199 µm (Table 4). The difference 
in the likelihood of obtaining a postoperative BCVA  1.0 
for preoperative FT of 300–399 µm and 200–299 µm was 
Table  3  Association  between  preoperative  decimal  best-
corrected visual acuity and postoperative decimal best-corrected 
visual acuity 1.0
Preoperative  
decimal BCVA
Eyes, no. Postoperative 6M decimal  
BCVA  1.0, no (%)
0.9 21 12 (57)
0.7–0.8 15 7 (47)
0.5–0.6 18 8 (44)
0.3–0.4 15 2 (13)
0.1–0.2 2 0 (0)
#0.09 2 0 (0)
Total 73 29 (40)
Notes: P = 0.002, Fisher’s exact probability test, 0.5 versus <0.5; P = 0.008, 
Fisher’s  exact  probability  test,  0.9  versus  0.3–0.4;  P  =  0.05,  Fisher’s  exact 
probability test, 0.7–0.8 versus 0.3–0.4; P = 0.06, Fisher’s exact probability test, 
0.5–0.6 versus 0.3–0.4; P = 0.21, Fisher’s exact probability test, 0.9 versus 0.5–0.6; 
P = 0.39, Fisher’s exact probability test, 0.9 versus 0.7–0.8; P = 0.46, Fisher’s exact 
probability test, 0.7–0.8 versus 0.5–0.6.
Abbreviation: BCVA, best-corrected visual acuity.
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Figure  1  Coefficients  of  correlation  between  postoperative  and  preoperative 
BCVA. The postoperative BCVA at 6 months is significantly correlated with the 
preoperative BCVA (r = 0.44, P , 0.001, Spearman’s rank correlation coefficient).
Abbreviations:  BCVA,  best-corrected  visual  acuity;  logMAr,  logarithm  of  the 
minimum angle of resolution.
0 100 200 300
Preoperative foveal thickness (µm)
P
o
s
t
o
p
e
r
a
t
i
v
e
 
B
C
V
A
(
l
o
g
M
A
R
)
4005 00 60 7008 00
0
0.5
1
1.5
2
−0.5
Figure 2 Coefficients of correlation between postoperative BCVA and preoperative 
foveal thickness. The postoperative BCVA at 6 months was significantly correlated 
with the preoperative foveal thickness (r = 0.24, P = 0.04, spearman’s rank correlation 
coefficient).
Abbreviations:  BCVA,  best-corrected  visual  acuity;  logMAr,  logarithm  of  the 
minimum angle of resolution.
Table 4 Association between preoperative foveal thickness and 
postoperative decimal best-corrected visual acuity 1.0
Preoperative foveal  
thickness (μm)
Eyes, no. Postoperative 6M decimal   
BCVA  1.0, no (%)
400 28 6 (21)
300–399 25 14 (56)
200–299 19 9 (47)
100–199 1 0 (0)
Total 73 29 (40)
Notes: P = 0.01, Fisher’s exact probability test, ≥400 µm versus <400 µm; P = 0.01, 
Fisher’s exact probability test, 400 µm versus 300–399 µm; P = 0.06, Fisher’s exact 
probability test, 400 µm versus 200–299 µm; P = 0.40, Fisher’s exact probability 
test, 300–399 µm versus 200–299 µm. 
Abbreviation: BCVA, best-corrected visual acuity.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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not significant (P = 0.40, Fisher’s exact probability test). In 
addition, the likelihood of obtaining a postoperative decimal 
BCVA  1.0 in eyes with a preoperative FT of  400 µm 
was significantly lower in eyes with a   preoperative FT 
of 300–399 µm (P = 0.01, Fisher’s exact probability 
test). However, this   relationship was not significant for 
preoperative FT of 200–299 µm (P = 0.06, Fisher’s exact 
probability test). A postoperative decimal BCVA  1.0 was 
obtained in 51% (23/45 eyes) of eyes with a preoperative FT 
, 400 µm, and the rate of obtaining a postoperative decimal 
BCVA  1.0 in eyes with a preoperative FT , 400 µm was 
significantly higher than that in eyes with an FT  400 µm 
(P = 0.01, Fisher’s exact probability test).
Association between preoperative findings and postopera-
tive decimal BCVA 1.0 are shown in Table 5. The incidence 
of obtaining a postoperative decimal BCVA  1.0 was signifi-
cantly higher in eyes with preoperative decimal BCVA  0.5 
and FT < 400 µm (60%) than in eyes with preoperative deci-
mal BCVA  0.5 and FT  400 µm (20%; P = 0.03, Fisher’s 
exact probability test) or preoperative BCVA < 0.5 and FT  
400 µm (7%; P < 0.001, Fisher’s exact probability test). 
A summary of the clinical data of the eyes that had a post-
operative decimal BCVA  1.0 or , 1.0 is shown in Table 6. 
Statistical analyses on the eyes with a postoperative decimal 
BCVA  1.0 or decimal BCVA , 1.0 showed that the gender, 
age, lens status, and surgical procedures were not significantly 
different in the two groups. The mean preoperative BCVA and 
visual improvement were 0.13 ± 0.15 and 0.18 ± 0.15   logMAR 
units in the   postoperative decimal BCVA  1.0 group, whereas 
they were 0.30 ± 0.29 and 0.05 ± 0.23 logMAR units in the 
postoperative decimal BCVA , 1.0 group (P = 0.004 and 
P = 0.01, Mann–  Whitney U test). The mean preoperative FT 
was thinner in the   postoperative decimal BCVA  1.0 group 
(P = 0.07, Mann–Whitney U test), but the difference was not 
significant, and the mean reduction of FT was significantly 
lower in the   postoperative   decimal BCVA  1.0 group than 
in the postoperative decimal BCVA , 1.0 group (P , 0.001, 
Mann–  Whitney U test). The mean preoperative FT was 
344 ± 73 µm in the postoperative decimal BCVA  1.0 group, 
which was not significantly thinner than the 389 ± 121 µm 
in the postoperative decimal BCVA , 1.0 group (P = 0.07, 
Mann–Whitney U test).   However, the FT was reduced by 
61 ± 35 µm in the postoperative decimal BCVA  1.0 group, 
which was significantly less than the 77 ± 48 µm in the 
postoperative decimal BCVA , 1.0 group (P , 0.001, 
Mann–Whitney U test).
Discussion
Our results showed that 25G-TSV and membranectomy 
used for the treatment of idiopathic ERMs were effec-
tive in significantly improving the BCVA and reducing 
the FT in patients with visual disturbances including 
decreased BCVA or metamorphopsia. In addition, we 
found that the   postoperative BCVA was correlated with 
the preoperative BCVA, preoperative FT, and postopera-
tive FT.   Approximately more than 50% of the eyes with a 
preoperative BCVA  0.5 and a preoperative FT , 400 µm 
attained a postoperative decimal BCVA  1.0. Our results 
also demonstrated that the preoperative BCVA was signifi-
cantly correlated not only with the postoperative BCVA 
but also with the improvement in the BCVA. Because 
the mean preoperative BCVA was significantly better in 
the postoperative decimal BCVA  1.0 group than in the 
postoperative decimal BCVA , 1.0 group, a good pre-
operative BCVA was necessary to obtain a postoperative 
decimal BCVA  1.0, ie, a preoperative decimal BCVA 
Table 5 Association between preoperative findings and postoperative decimal best-corrected visual acuity 1.0
Group Preoperative findings Eyes, no. Postoperative 6M decimal   
BCVA  1.0, no (%)
1 Decimal BCVA  0.5 and FT , 400  40 24 (60)
2 Decimal BCVA  0.5 and FT 400  10 2 (20)
3 Decimal BCVA , 0.5 and FT , 400  8 2 (25)
4 Decimal BCVA , 0.5 and FT 400 15 1 (7)
Total 73 29 (40)
P = 0.03, Fisher’s exact probability test, group 1 versus group 2.
P = 0.08, Fisher’s exact probability test, group 1 versus group 3.
P , 0.001, Fisher’s exact probability test, group 1 versus group 4.
P = 0.62, Fisher’s exact probability test, group 2 versus group 3.
P = 0.35, Fisher’s exact probability test, group 2 versus group 4.
P = 0.27, Fisher’s exact probability test, group 3 versus group 4.
Abbreviations: BCVA = best-corrected visual acuity; FT = foveal thickness (µm).Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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of  0.5. Our findings indicated that the reduction of the 
FT was significantly lower in the postoperative decimal 
BCVA  1.0 group, which was also reasonable because 
the reduction of FT was significantly correlated with pre-
operative BCVA (logMAR). On the other hand, although 
eyes with good preoperative BCVA showed a decreased 
likelihood of visual improvements, the improvement of 
the BCVA was significantly higher in the postoperative 
decimal BCVA  1.0 group than in the postoperative 
decimal BCVA , 1.0 group. The reason for this is unclear. 
However, the status of the photoreceptor inner and outer 
segment (IS/OS) or external limiting membrane (ELM) 
might be one of the explanations for this. The use of a 
spectral domain OCT would have helped in evaluating the 
photoreceptor integrity in more detail.
A postoperative decimal BCVA  1.0 also correlated with 
a preoperative FT of ,400 µm. We suggest that because the 
preoperative FT was significantly correlated with the preop-
erative BCVA and the postoperative BCVA, the   postoperative 
BCVA was worse in eyes with thicker preoperative FT. If the 
preoperative FT was  400 µm, the preoperative decimal 
BCVA might be too low to attain a postoperative decimal 
BCVA  1.0, even if the visual improvement was high. Thus, 
if the effects of the ERM had progressed to cause a lower deci-
mal BCVA and thicker FT, the postoperative visual recovery 
of decimal BCVA  1.0 would not be expected, in spite of a 
larger FT reduction and improvement in BCVA. We conclude 
that the eyes with both preoperative FT , 400 µm and preop-
erative decimal BCVA  0.5 were the best candidates to obtain 
a   postoperative decimal BCVA of 1.0 postoperatively.
The improvement of the BCVA and reduction of the FT 
following surgery have been reported in the literature.7,13–16 
Several studies have reported that the preoperative FT was 
significantly correlated with the preoperative BCVA, but the 
postoperative FT was not significantly correlated with the 
postoperative BCVA.15,17,18 However, a study by Suh et al 
reported that the postoperative FT was significantly correlated 
with the postoperative BCVA after ERM surgery, which is 
similar to our study.19 Discrepancies in the association of the 
postoperative BCVA and FT in earlier studies are probably 
Table 6 summary of clinical data by postoperative decimal best-corrected visual acuity 1.0 or ,1.0
Postoperative  
decimal BCVA  1.0
Postoperative  
decimal BCVA , 1.0
P value
no. eyes 29 44
no. patients 29 44
gender (no./%) 0.08*
  Male 13 (45) 11 (25)
  Female 16 (55) 33 (75)
Age (yrs)
  Mean ± sD 65.9 ± 12.8 68.1 ± 8.5 0.57#
  Median 68 67
  range 27–87 50–82
Lens status (baseline; no./%) 0.69*
  Phakic 24 (83) 37 (84)
  Pseudophakic 5 (17) 7 (16)
surgical procedure (no./%) 0.35*
  25g-TsV 14 (48) 18 (36)
  Triple surgery 15 (52) 26 (64)
Decimal BCVA (mean)
  Baseline 0.74 0.50
  Postoperative 6M 1.10 0.56
BCVA (logMAr; mean ± sD)
  Baseline 0.13 ± 0.15 0.30 ± 0.29 0.004#
  Postoperative 6M -0.04 ± 0.07 0.25 ± 0.29 ,0.001#
  improvement 0.18 ± 0.15 0.05 ± 0.23 0.01#
Foveal thickness (µm; mean ± sD)
  Baseline 344 ± 73 389 ± 121 0.07#
  Postoperative 6M 283 ± 39 312 ± 78 0.11#
  reduction 61 ± 35 77 ± 48 ,0.001#
Notes: *Fisher’s exact probability test; #Mann–Whitney test. Triple surgery, phacoemulsification and aspiration, intraocular lens implant, and 25-gauge transconjunctival 
sutureless vitrectomy.
Abbreviations: sD, standard deviation; 25g-TsV, 25-gauge transconjunctival sutureless vitrectomy; BCVA, best-corrected visual acuity; logMAr, logarithm of the minimum 
angle of resolution. Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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good visual acuity after 25-gauge vitrectomy for erM
due to different surgical procedures and low uniformity of 
various interventions, including ILM removal, dye used, and 
vitrectomy instruments (20 gauge or 25 gauge). If the ILM 
was completely removed as in the study by Shimada et al and 
this study, the residual ILM might not influence the postop-
erative macular surface to worsen the FT and BCVA.20
The removal of the ILM is still controversial because 
electrophysiological studies have shown some retinal dys-
function following ILM removal and because the use of dye 
had some retinal toxicity.21,22 However, studies have shown 
a decrease in the recurrences of ERM after ILM peeling 
and improvement of the BCVA and FT.20,23–25 Our results 
showed a 1.4% (1/73 eyes) recurrence rate after more than 
a mean postoperative period of 9 months.
Because the IS/OS were not evaluated in the study pre-
sented, there have been two recent reports that discussed 
the association between the preoperative OCT images of 
the IS/OS junction of the photoreceptors and the visual out-
comes after ERM surgery.17,19 We did not study the IS/OS 
junction as a prognostic factor because we were not able 
to precisely detect it because of the low resolution of the 
OCT we used. In addition, the IS/OS junction is difficult 
to detect when the FT is thick. Although it is more diffi-
cult to detect the ELM by low-resolution OCT, we believe 
that the BCVA in eyes with ERM would be correlated also 
with the status of ELM if it could be detected.26,27 However, 
because our results showed that eyes with postoperative 
decimal BCVA  1.0 had good preoperative BCVA, and 
because the nonoperated ERM eyes with photoreceptor 
defects have significantly lower visual acuity,28 all of our 
cases that had a postoperative BCVA  1.0 probably had 
a distinct IS/OS junction and ELM in the fovea. Thus, 
we believe that the preoperative BCVA and FT could be 
prognostic parameters for all ophthalmologists without 
knowing precisely the status of the IS/OS junction and 
even an ELM.
The duration of symptoms was not studied as a prognostic 
factor28,29 because the exact onset of the ERM, especially if 
the patients had good BCVA, is uncertain.
There are limitations of our study, including its retro-
spective nature, short follow-up period, small number of 
patients, and use of time-domain OCT. In addition, although 
a final decimal BCVA of 1.0 is only one aspect of the visual 
benefit in ERM surgery, and the degree of visual improve-
ment and reduction of metamorphopsia are also important 
benefits of this surgery, the aim of this study was to identify 
factors that led to a postoperative decimal BCVA  1.0. 
Nevertheless, our findings indicate that surgery with 
25G-TSV/membranectomy for idiopathic ERM is a useful 
method to obtain good decimal BCVA  1.0 postopera-
tively. Based on our study results, a postoperative decimal 
BCVA of  1.0 can be achieved in patients whose preop-
erative decimal BCVA has not deteriorated beyond 0.5 and 
whose central macular thickness has not exceeded 400 µm. 
However, many patients in this range of vision and FT are 
asymptomatic, and we should remember that all surgery 
carries inherent risks.
In conclusion, our findings indicate that eyes with both 
preoperative BCVA  0.5 and FT , 400 µm have a sig-
nificantly better chance of obtaining a postoperative decimal 
BCVA  1.0 following removal of the idiopathic ERM.
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